Schedule 13G ownership disclosure

BRIACELL THERAPEUTICS ORD

Security class unavailable · CUSIP: 10778Y302

Event date: 2021-02-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
555,000
Percent of class
9.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000082
Form type
SC 13G
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Mar 03, 2021
Reporting period
Feb 24, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub